LR, B., AE, A., HC, R., & PK, L. (2017). A Novel Alternate Dosing of Vismodegib for Treatment of Patients With Advanced Basal Cell Carcinomas. JAMA dermatology, 153(4), 321. https://doi.org/10.1001/jamadermatol.2016.5058
Chicago Style (17th ed.) CitationLR, Becker, Aakhus AE, Reich HC, and Lee PK. "A Novel Alternate Dosing of Vismodegib for Treatment of Patients With Advanced Basal Cell Carcinomas." JAMA Dermatology 153, no. 4 (2017): 321. https://doi.org/10.1001/jamadermatol.2016.5058.
MLA (9th ed.) CitationLR, Becker, et al. "A Novel Alternate Dosing of Vismodegib for Treatment of Patients With Advanced Basal Cell Carcinomas." JAMA Dermatology, vol. 153, no. 4, 2017, p. 321, https://doi.org/10.1001/jamadermatol.2016.5058.
Warning: These citations may not always be 100% accurate.